Mustang Bio Stock Total Asset
MBIO Stock | USD 0.35 0.01 2.78% |
Mustang Bio fundamentals help investors to digest information that contributes to Mustang Bio's financial success or failures. It also enables traders to predict the movement of Mustang Stock. The fundamental analysis module provides a way to measure Mustang Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mustang Bio stock.
Last Reported | Projected for Next Year | ||
Total Assets | 17.7 M | 16.9 M | |
Intangibles To Total Assets | 0.00 | 0.00 |
Mustang | Total Asset |
Mustang Bio Company Total Asset Analysis
Mustang Bio's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Mustang Bio Total Asset | 17.74 M |
Most of Mustang Bio's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mustang Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Mustang Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Mustang Bio is extremely important. It helps to project a fair market value of Mustang Stock properly, considering its historical fundamentals such as Total Asset. Since Mustang Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mustang Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mustang Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Mustang Total Asset Historical Pattern
Today, most investors in Mustang Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mustang Bio's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Mustang Bio total asset as a starting point in their analysis.
Mustang Bio Total Asset |
Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition |
Mustang Net Tangible Assets
Net Tangible Assets |
|
Based on the latest financial disclosure, Mustang Bio has a Total Asset of 17.74 M. This is 99.76% lower than that of the Biotechnology sector and 99.1% lower than that of the Health Care industry. The total asset for all United States stocks is 99.94% higher than that of the company.
Mustang Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mustang Bio's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mustang Bio could also be used in its relative valuation, which is a method of valuing Mustang Bio by comparing valuation metrics of similar companies.Mustang Bio is currently under evaluation in total asset category among related companies.
Mustang Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Mustang Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Mustang Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Mustang Bio's value.Shares | Macquarie Group Ltd | 2023-12-31 | 8 K | Fmr Inc | 2023-12-31 | 7.2 K | Tower Research Capital Llc | 2023-12-31 | 6.4 K | U.s. Bancorp | 2023-12-31 | 1000 | Ubs Group Ag | 2023-12-31 | 1000 | Nbc Securities Inc | 2023-09-30 | 400 | Advisor Group Holdings, Inc. | 2023-12-31 | 361 | Bank Of America Corp | 2023-12-31 | 211 | Wells Fargo & Co | 2023-12-31 | 150 | Armistice Capital, Llc | 2023-12-31 | 435.8 K | Vanguard Group Inc | 2023-12-31 | 179.6 K |
Mustang Fundamentals
Return On Equity | -2.22 | ||||
Return On Asset | -0.58 | ||||
Current Valuation | (225.35 K) | ||||
Shares Outstanding | 9.54 M | ||||
Shares Owned By Insiders | 22.76 % | ||||
Shares Owned By Institutions | 10.10 % | ||||
Number Of Shares Shorted | 177.98 K | ||||
Price To Earning | (11.40) X | ||||
Price To Book | 42.91 X | ||||
EBITDA | (48.5 M) | ||||
Net Income | (51.6 M) | ||||
Cash And Equivalents | 107.37 M | ||||
Cash Per Share | 1.01 X | ||||
Total Debt | 2.5 M | ||||
Debt To Equity | 0.35 % | ||||
Current Ratio | 9.96 X | ||||
Book Value Per Share | 0.01 X | ||||
Cash Flow From Operations | (49.48 M) | ||||
Short Ratio | 0.54 X | ||||
Earnings Per Share | (6.00) X | ||||
Target Price | 14.33 | ||||
Number Of Employees | 80 | ||||
Beta | 1.54 | ||||
Market Capitalization | 3.74 M | ||||
Total Asset | 17.74 M | ||||
Retained Earnings | (380.97 M) | ||||
Working Capital | (4.03 M) | ||||
Current Asset | 42.37 M | ||||
Current Liabilities | 3.93 M | ||||
Net Asset | 17.74 M |
About Mustang Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mustang Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mustang Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mustang Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Mustang Bio Piotroski F Score and Mustang Bio Altman Z Score analysis. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Mustang Stock analysis
When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.00) | Revenue Per Share (0) | Return On Assets (0.58) | Return On Equity (2.22) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.